/
Front. Oncol
A molecularly characterized preclinical platform of subcutaneous renal cell carcinoma (RCC) patient-derived xenograft models to evaluate novel treatment strategies
- D. Gürgen
- M. Becker
- M. Dahlmann
- S. Flechsig
- E. Schaeffeler
- F.A. Büttner
- C. Schmees
- R. Bohnert
- J. Bedke
- M. Schwab
- J.J. Wendler
- M. Schostak
- B. Jandrig
- W. Walther
- J. Hoffmann